Abstract: Systems and methods are described in which the location of a tap on the body of a handheld device is determined in real time using data streams from an embedded inertial measurement unit (IMU). Taps may be generated by striking the handheld device with an object (e.g., a finger), or by moving the handheld device in a manner that causes it to strike another object. IMU accelerometer, gyroscopic and/or orientation (relative to the magnetic and/or gravitational pull of the earth) measurements are examined for signatures that distinguish a tap at a location on the body of the device compared with signal characteristics produced by taps at other locations. Neural network and/or numerical methods may be used to perform such classifications.

Abstract: An absorbent article includes a first waist region, a second waist region and a crotch region disposed between the first and second waist regions. The absorbent article further includes a topsheet, a backsheet, an absorbent core disposed between the topsheet and the backsheet, and a laminate. The laminate has an elasticized region. The laminate includes a first nonwoven, a second nonwoven and an elastomeric material sandwiched between said first and second nonwovens in the elasticized region. The laminate includes a bonding region with a bond density of at least 4% and at least partially overlapping the elastomeric material. The laminate exhibits an Unload Force at 50% of at least 0.90 N.

Abstract: The present disclosure is directed to monoclonal antibodies, or antigen-binding fragments thereof, that bind to coronavirus spike proteins, including the spike protein of SARS-CoV-2. These antibodies demonstrate high affinity binding to epitopes on the coronavirus spike protein and/or broad cross-reactivity to the spike protein of various coronaviruses. Compositions comprising the anti-coronavirus antibodies, nucleic acids encoding for the antibodies, recombinant expression vectors, and host cells are also disclosed. The present disclosure is also directed to methods of diagnosing, preventing or treating coronavirus infections, including infections or disease caused by SARS-CoV-2.

Abstract: According to examples, an apparatus includes a processor that is to cause an application to be provided through which information pertaining to a first user is to be displayed, receive authentication information of a second user, in which the authentication information includes an identifier of the second user and information that the second user uses for authentication to access a web-based application, determine whether the identifier of the second user is linked to an identifier of the first user, determine whether the authentication information authenticates the second user to access the web-based application, and based on a determination that the identifier of the second user is linked to the identifier of the first user and the authentication information authenticates the second user to access the web-based application, perm it the second user to access the information pertaining to the first user through the application.

Abstract: The present disclosure relates to processing operations configured to improve data provisioning for management of access to and usage of domain-specific data through a software data platform. Processing described herein provides technical advantages, provided through a software data platform, that enable a user (e.g., an administrator) of an organization to more easily integrate and manage domain-specific data within a software data platform. For instance, a graphical user interface (GUI) of a software data platform is configured to provide a user (e.g., administrative user) with control over provisioning of their data (e.g., education data) including bulk provisioning options to manage utilization and sharing of data via a software data platform. Provisioning management may comprise control over sharing permissions of domain-specific data with vendors (e.g.

Abstract: The present disclosure relates to processing operations configured to improve data provisioning for management of access to and usage of domain-specific data through a software data platform. Processing described herein provides technical advantages, provided through a software data platform, that enable a user (e.g., an administrator) of an organization to more easily integrate and manage domain-specific data within a software data platform. For instance, a graphical user interface (GUI) of a software data platform is configured to provide a user (e.g., administrative user) with control over provisioning of their data (e.g., education data) including bulk provisioning options to manage utilization and sharing of data via a software data platform. Provisioning management may comprise control over sharing permissions of domain-specific data with vendors (e.g.

Abstract: The present disclosure relates to processing operations configured to improve data ingestion processing for management of domain-specific data through a software data platform. Processing described herein provides technical advantages, provided through a software data platform, that enable a user (e.g., an administrator) of an organization to more easily integrate and manage domain-specific data within a software data platform. A graphical user interface (GUI) of a software data platform is configured to guide an administrative user through data mapping processing so that the administrator can more easily integrate its organizational data into the software data platform. Insights may be automatically generated and provided to the user through the GUI, which may help to guide the administrator through the data mapping process. In further examples, generated insights may be provided as recommendations (or autocorrections) designed to foster a successful data mapping to aid provisioning of data.

Abstract: The present disclosure relates to processing operations configured to improve data provisioning for management of access to and usage of domain-specific data through a software data platform. Processing described herein provides technical advantages, provided through a software data platform, that enable a user (e.g., an administrator) of an organization to more easily integrate and manage domain-specific data within a software data platform. For instance, a graphical user interface (GUI) of a software data platform is configured to provide a user (e.g., administrative user) with control over provisioning of their data (e.g., education data) including bulk provisioning options to manage utilization and sharing of data via a software data platform. Provisioning management may comprise control over sharing permissions of domain-specific data with vendors (e.g.

Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Abstract: The invention is generally directed to V1V2 immunogens.

Abstract: The present invention relates, in general, to antibody-dependent cellular cytoxicity (ADCC)-mediating antibodies, and, in particular, to ADCC-mediating antibodies (and fragments thereof) suitable for use, for example, in reducing the risk of HIV-1 infection in a subject. The invention further relates to compositions comprising such antibodies or antibody fragments.

Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Abstract: The present invention relates, in general to herpes simplex virus (HSV) and, particular, to antibodies that are specific for glycoprotein D (gD) of HSV. The invention also relates to prophylactic and therapeutic uses of such antibodies.

Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Abstract: An apparatus for cyclically actuating an actuation member comprises a hollow shaft rotatable about an axis of rotation and defining therein a cam opening therethrough, an inner shaft rotatably carried within the hollow shaft, a cam member fixed to the hollow shaft adjacent the cam opening, a cam member fixed to the inner shaft and projecting through the cam opening of the hollow shaft, a variable transmission having a reference element connected to one of the shafts and an output element connected to the other of the shafts, and an input element; a pulley wheel connected to the shafts for rotating same about the axis, and an electric motor connected to the input element of the variable transmission for rotating same, the electric motor being controlled by an electronic control unit which can include one or more microprocessor units.